Edition:
United Kingdom

Healthcare

GSK.L
AZN.L
SHP.L

BRIEF-Bristol-Myers Says in May sold business comprising an alliance with Reckitt Benckiser

* Bristol Myers Squibb - In May 2016, co sold the business comprising an alliance with Reckitt Benckiser Group including several OTC products sold primarily in Mexico and Brazil

4:45pm BST

BRIEF-Germany's Merck KGaA, AmoyDx collaborate to bring liquid biopsy RAS biomarker testing to China

* Merck and Amoy Diagnostics Co Ltd collaborate to bring liquid biopsy RAS biomarker testing to China

4:31pm BST

U.S. and UK form global partnership to speed new antibiotics

LONDON, July 28 U.S. and British health officials have created a new alliance with a budget of hundreds of millions of dollars to accelerate the development of new antibiotics and tackle the growing problem of drug resistance.

4:29pm BST

BRIEF-Adaptimmune gets priority medicines regulatory support for its Spear T-cell therapy

* Adaptimmune receives access to priority medicines (PRIME) regulatory support for its Spear T-cell therapy targeting NY-ESO for treatment of soft tissue sarcoma Source text for Eikon: Further company coverage:

4:27pm BST

UPDATE 3-Bristol-Myers shares hit by decline of Yervoy melanoma drug

July 28 Bristol-Myers Squibb Co reported disappointing second-quarter sales of its Yervoy melanoma treatment on Thursday, raising concerns about the long-term prospects for one of its most important cancer medicines and sending its shares lower.

4:23pm BST
Healthcare
GlaxoSmithKline PLC 1,699.50p +0.18%
AstraZeneca PLC 5,027.00p +7.19%
Shire PLC 4,818.00p -1.79%

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.